BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15793119)

  • 21. [Resistant mutant prevention concentration of fluoroquinolones in clinical isolates of extended spectrum beta-lactamase (ESBL) producing and non-producing strains of Escherichia coli].
    Noguera O; Rodríguez JC; López JM; Ruiz M; Royo G
    Rev Esp Quimioter; 2009 Mar; 22(1):30-3. PubMed ID: 19308744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the genetic structure and transmission mechanism of a plasmid-mediated AmpC beta-lactamase].
    Lu WX; Wei ZQ; Yu YS; Chen YG; Li LJ
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3043-7. PubMed ID: 16324403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of high-level ceftazidime resistance via single-base substitutions of blaCTX-M-3 in hyper-mutable Escherichia coli.
    Karisik E; Ellington MJ; Pike R; Livermore DM; Woodford N
    Clin Microbiol Infect; 2006 Aug; 12(8):803-6. PubMed ID: 16842579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.
    Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended-spectrum-beta-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program.
    Kojima A; Ishii Y; Ishihara K; Esaki H; Asai T; Oda C; Tamura Y; Takahashi T; Yamaguchi K
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3533-7. PubMed ID: 16048977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a chromosome-borne class C beta-lactamase from Erwinia rhapontici.
    Naas T; Aubert D; Vimont S; Nordmann P
    J Antimicrob Chemother; 2004 Nov; 54(5):932-5. PubMed ID: 15472000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
    Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase.
    Fernández-Cuenca F; Rodríguez-Martínez JM; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2006 Jun; 27(6):549-52. PubMed ID: 16697150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amp C beta-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and therapeutic challenge.
    Fakioglu E; Queenan AM; Bush K; Jenkins SG; Herold BC
    J Perinatol; 2006 Aug; 26(8):515-7. PubMed ID: 16871223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance.
    Fernebro J; Andersson I; Sublett J; Morfeldt E; Novak R; Tuomanen E; Normark S; Normark BH
    J Infect Dis; 2004 Jan; 189(2):328-38. PubMed ID: 14722899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity, beta-lactamase stability and PBP affinity of RU 51,746-2, the active metabolite of the new orally absorbed cephalosporin ester, RU 51807.
    Boaretti M; Lleó MM; Canepari P
    J Chemother; 1991 Jan; 3 Suppl 1():57-61. PubMed ID: 12041787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.
    Colodner R; Samra Z; Keller N; Sprecher H; Block C; Peled N; Lazarovitch T; Bardenstein R; Schwartz-Harari O; Carmeli Y;
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):201-5. PubMed ID: 17258084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SHV-5 extended-spectrum beta-lactamases in clinical isolates of Escherichia coli in Malaysia.
    Subramaniam G; Palasubramaniam S; Navaratnam P
    Indian J Med Microbiol; 2006 Jul; 24(3):205-7. PubMed ID: 16912441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of N-acetylmuramyl-L-alanine amidases in cell separation and antibiotic-induced autolysis of Escherichia coli.
    Heidrich C; Templin MF; Ursinus A; Merdanovic M; Berger J; Schwarz H; de Pedro MA; Höltje JV
    Mol Microbiol; 2001 Jul; 41(1):167-78. PubMed ID: 11454209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
    Vo AT; van Duijkeren E; Fluit AC; Gaastra W
    Vet Microbiol; 2007 Oct; 124(3-4):248-55. PubMed ID: 17521833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.
    Tracz DM; Boyd DA; Hizon R; Bryce E; McGeer A; Ofner-Agostini M; Simor AE; Paton S; Mulvey MR;
    FEMS Microbiol Lett; 2007 May; 270(2):265-71. PubMed ID: 17326753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.
    Brenwald NP; Andrews J; Fraise AP
    J Antimicrob Chemother; 2006 Jul; 58(1):223-4. PubMed ID: 16698846
    [No Abstract]   [Full Text] [Related]  

  • 40. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
    Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW
    Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.